Serial Number | 97278111 |
Word Mark | DERMAGAN |
Filing Date | Tuesday, February 22, 2022 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Friday, April 21, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Pharmaceutical research and development; Pharmaceutical products development; Product development in the field nutritional supplements for dietary purposes; Scientific research, product research and development services for nutritional and skin care formulations, namely, nutritional supplements, skin care formulations, pharmaceuticals, nutraceuticals, and cosmeceuticals |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 28, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Dermagan Pharmaceuticals LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Scottsdale, AZ 85255 |
Event Date | Event Description |
Friday, April 21, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Friday, April 21, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Friday, April 21, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Thursday, September 22, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, September 22, 2022 | NON-FINAL ACTION E-MAILED |
Thursday, September 22, 2022 | NON-FINAL ACTION WRITTEN |
Wednesday, September 21, 2022 | ASSIGNED TO EXAMINER |
Monday, February 28, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, February 25, 2022 | NEW APPLICATION ENTERED |